Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 8/2016

01-08-2016 | Original Article

Survey of laboratory-acquired infections around the world in biosafety level 3 and 4 laboratories

Authors: N. Wurtz, A. Papa, M. Hukic, A. Di Caro, I. Leparc-Goffart, E. Leroy, M. P. Landini, Z. Sekeyova, J. S. Dumler, D. Bădescu, N. Busquets, A. Calistri, C. Parolin, G. Palù, I. Christova, M. Maurin, B. La Scola, D. Raoult

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 8/2016

Login to get access

Abstract

Laboratory-acquired infections due to a variety of bacteria, viruses, parasites, and fungi have been described over the last century, and laboratory workers are at risk of exposure to these infectious agents. However, reporting laboratory-associated infections has been largely voluntary, and there is no way to determine the real number of people involved or to know the precise risks for workers. In this study, an international survey based on volunteering was conducted in biosafety level 3 and 4 laboratories to determine the number of laboratory-acquired infections and the possible underlying causes of these contaminations. The analysis of the survey reveals that laboratory-acquired infections have been infrequent and even rare in recent years, and human errors represent a very high percentage of the cases. Today, most risks from biological hazards can be reduced through the use of appropriate procedures and techniques, containment devices and facilities, and the training of personnel.
Literature
1.
go back to reference Pike RM (1976) Laboratory-associated infections: summary and analysis of 3921 cases. Health Lab Sci 13:105–114PubMed Pike RM (1976) Laboratory-associated infections: summary and analysis of 3921 cases. Health Lab Sci 13:105–114PubMed
2.
go back to reference Harding LH, Byers KB (2006) Epidemiology of laboratory-acquired infections. In: Fleming DO, Hunt DL (eds) Biological safety: principles and practices, 4th edn. ASM Press, Washington, DC Harding LH, Byers KB (2006) Epidemiology of laboratory-acquired infections. In: Fleming DO, Hunt DL (eds) Biological safety: principles and practices, 4th edn. ASM Press, Washington, DC
3.
go back to reference Henkel RD, Miller T, Weyant RS (2012) Monitoring select agent theft, loss and release reports in the United States—2004–2010. Appl Biosafety 17:171–180CrossRef Henkel RD, Miller T, Weyant RS (2012) Monitoring select agent theft, loss and release reports in the United States—2004–2010. Appl Biosafety 17:171–180CrossRef
4.
go back to reference Mattar ZR, Abugiazya A, Torok N, Assaly R (2009) Laboratory-acquired coccodioidmycosis. Chest 136:28SCrossRef Mattar ZR, Abugiazya A, Torok N, Assaly R (2009) Laboratory-acquired coccodioidmycosis. Chest 136:28SCrossRef
5.
go back to reference Kaye D (2005) Tularemia, laboratory acquired. Clin Infect Dis 40:3–4 Kaye D (2005) Tularemia, laboratory acquired. Clin Infect Dis 40:3–4
7.
go back to reference Normile D (2004) Infectious diseases. Mounting lab accidents raise SARS fears. Science 304:659–661CrossRefPubMed Normile D (2004) Infectious diseases. Mounting lab accidents raise SARS fears. Science 304:659–661CrossRefPubMed
9.
go back to reference Wurtz N, Grobusch MP, Raoult D (2014) Negative impact of laws regarding biosecurity and bioterrorism on real diseases. Clin Microbiol Infect 20:507–515CrossRefPubMed Wurtz N, Grobusch MP, Raoult D (2014) Negative impact of laws regarding biosecurity and bioterrorism on real diseases. Clin Microbiol Infect 20:507–515CrossRefPubMed
10.
go back to reference Günther S, Feldmann H, Geisbert TW, Hensley LE, Rollin PE, Nichol ST et al (2011) Management of accidental exposure to Ebola virus in the biosafety level 4 laboratory, Hamburg, Germany. J Infect Dis 204:S785–S790 Günther S, Feldmann H, Geisbert TW, Hensley LE, Rollin PE, Nichol ST et al (2011) Management of accidental exposure to Ebola virus in the biosafety level 4 laboratory, Hamburg, Germany. J Infect Dis 204:S785–S790
14.
go back to reference Centers for Disease Control and Prevention (CDC) (2011) Fatal laboratory-acquired infection with an attenuated Yersinia pestis strain—Chicago, Illinois, 2009. MMWR Morb Mortal Wkly Rep 60:201–205 Centers for Disease Control and Prevention (CDC) (2011) Fatal laboratory-acquired infection with an attenuated Yersinia pestis strain—Chicago, Illinois, 2009. MMWR Morb Mortal Wkly Rep 60:201–205
15.
go back to reference Barry M, Russi M, Armstrong L, Geller D, Tesh R, Dembry L et al (1995) Brief report: treatment of a laboratory-acquired Sabiá virus infection. N Engl J Med 333:294–296CrossRefPubMed Barry M, Russi M, Armstrong L, Geller D, Tesh R, Dembry L et al (1995) Brief report: treatment of a laboratory-acquired Sabiá virus infection. N Engl J Med 333:294–296CrossRefPubMed
16.
go back to reference Vasconcelos PF, Travassos da Rosa AP, Rodrigues SG, Tesh R, Travassos da Rosa JF, Travassos da Rosa ES (1993) Laboratory-acquired human infection with SP H 114202 virus (Arenavirus: Arenaviridae family): clinical and laboratory aspects. Rev Inst Med Trop Sao Paulo 35:521–525PubMed Vasconcelos PF, Travassos da Rosa AP, Rodrigues SG, Tesh R, Travassos da Rosa JF, Travassos da Rosa ES (1993) Laboratory-acquired human infection with SP H 114202 virus (Arenavirus: Arenaviridae family): clinical and laboratory aspects. Rev Inst Med Trop Sao Paulo 35:521–525PubMed
17.
go back to reference Formenty P, Hatz C, Le Guenno B, Stoll A, Rogenmoser P, Widmer A (1999) Human infection due to Ebola virus, subtype Côte d’Ivoire: clinical and biologic presentation. J Infect Dis 179:S48–S53CrossRefPubMed Formenty P, Hatz C, Le Guenno B, Stoll A, Rogenmoser P, Widmer A (1999) Human infection due to Ebola virus, subtype Côte d’Ivoire: clinical and biologic presentation. J Infect Dis 179:S48–S53CrossRefPubMed
19.
go back to reference Beer B, Kurth R, Bukreyev A (1999) Characteristics of Filoviridae: Marburg and Ebola viruses. Naturwissenschaften 86:8–17CrossRefPubMed Beer B, Kurth R, Bukreyev A (1999) Characteristics of Filoviridae: Marburg and Ebola viruses. Naturwissenschaften 86:8–17CrossRefPubMed
20.
go back to reference Nikiforov VV, Turovskiĭ I, Kalinin PP, Akinfeeva LA, Katkova LR, Barmin VS et al (1994) A case of a laboratory infection with Marburg fever. Zh Mikrobiol Epidemiol Immunobiol 3:104–106PubMed Nikiforov VV, Turovskiĭ I, Kalinin PP, Akinfeeva LA, Katkova LR, Barmin VS et al (1994) A case of a laboratory infection with Marburg fever. Zh Mikrobiol Epidemiol Immunobiol 3:104–106PubMed
21.
22.
23.
go back to reference Lim PL, Kurup A, Gopalakrishna G, Chan KP, Wong CW, Ng LC et al (2004) Laboratory-acquired severe acute respiratory syndrome. N Engl J Med 350:1740–1745CrossRefPubMed Lim PL, Kurup A, Gopalakrishna G, Chan KP, Wong CW, Ng LC et al (2004) Laboratory-acquired severe acute respiratory syndrome. N Engl J Med 350:1740–1745CrossRefPubMed
24.
go back to reference Centers for Disease Control and Prevention (CDC) (2002) Suspected cutaneous anthrax in a laboratory worker—Texas, 2002. JAMA 287:2356–2358 Centers for Disease Control and Prevention (CDC) (2002) Suspected cutaneous anthrax in a laboratory worker—Texas, 2002. JAMA 287:2356–2358
25.
go back to reference Traxler RM, Lehman MW, Bosserman EA, Guerra MA, Smith TL (2013) A literature review of laboratory-acquired brucellosis. J Clin Microbiol 51:3055–3062CrossRefPubMedPubMedCentral Traxler RM, Lehman MW, Bosserman EA, Guerra MA, Smith TL (2013) A literature review of laboratory-acquired brucellosis. J Clin Microbiol 51:3055–3062CrossRefPubMedPubMedCentral
26.
go back to reference Centers for Disease Control and Prevention (CDC) (2000) Laboratory-acquired human glanders—Maryland, May 2000. MMWR Morb Mortal Wkly Rep 49:532–535 Centers for Disease Control and Prevention (CDC) (2000) Laboratory-acquired human glanders—Maryland, May 2000. MMWR Morb Mortal Wkly Rep 49:532–535
27.
go back to reference Srinivasan A, Kraus CN, DeShazer D, Becker PM, Dick JD, Spacek L et al (2001) Glanders in a military research microbiologist. N Engl J Med 345:256–258CrossRefPubMed Srinivasan A, Kraus CN, DeShazer D, Becker PM, Dick JD, Spacek L et al (2001) Glanders in a military research microbiologist. N Engl J Med 345:256–258CrossRefPubMed
28.
go back to reference Schlech WF 3rd, Turchik JB, Westlake RE Jr, Klein GC, Band JD, Weaver RE (1981) Laboratory-acquired infection with Pseudomonas pseudomallei (melioidosis). N Engl J Med 305:1133–1135CrossRefPubMed Schlech WF 3rd, Turchik JB, Westlake RE Jr, Klein GC, Band JD, Weaver RE (1981) Laboratory-acquired infection with Pseudomonas pseudomallei (melioidosis). N Engl J Med 305:1133–1135CrossRefPubMed
29.
go back to reference Janovská S, Pávková I, Reichelová M, Hubáleka M, Stulík J, Macela A (2007) Proteomic analysis of antibody response in a case of laboratory-acquired infection with Francisella tularensis subsp. tularensis. Folia Microbiol (Praha) 52:194–198CrossRef Janovská S, Pávková I, Reichelová M, Hubáleka M, Stulík J, Macela A (2007) Proteomic analysis of antibody response in a case of laboratory-acquired infection with Francisella tularensis subsp. tularensis. Folia Microbiol (Praha) 52:194–198CrossRef
30.
go back to reference Barry MA (2005) Report of pneumonic tularemia in three Boston University researchers. Boston Public Health Commission Barry MA (2005) Report of pneumonic tularemia in three Boston University researchers. Boston Public Health Commission
31.
go back to reference Lam ST, Sammons-Jackson W, Sherwood J, Ressner R (2012) Laboratory-acquired tularemia successfully treated with ciprofloxacin: a case report. Infect Dis Clin Pract 20:204–207CrossRef Lam ST, Sammons-Jackson W, Sherwood J, Ressner R (2012) Laboratory-acquired tularemia successfully treated with ciprofloxacin: a case report. Infect Dis Clin Pract 20:204–207CrossRef
32.
go back to reference Kawamata J, Yamanouchi T, Dohmae K, Miyamoto H, Takahaski M, Yamanishi K et al (1987) Control of laboratory acquired hemorrhagic fever with renal syndrome (HFRS) in Japan. Lab Anim Sci 37:431–436PubMed Kawamata J, Yamanouchi T, Dohmae K, Miyamoto H, Takahaski M, Yamanishi K et al (1987) Control of laboratory acquired hemorrhagic fever with renal syndrome (HFRS) in Japan. Lab Anim Sci 37:431–436PubMed
33.
go back to reference Nielsen CF, Sethi V, Petroll AE, Kazmierczak J, Erickson BR, Nichol ST et al (2010) Seoul virus infection in a Wisconsin patient with recent travel to China, March 2009: first documented case in the Midwestern United States. Am J Trop Med Hyg 83:1266–1268CrossRefPubMedPubMedCentral Nielsen CF, Sethi V, Petroll AE, Kazmierczak J, Erickson BR, Nichol ST et al (2010) Seoul virus infection in a Wisconsin patient with recent travel to China, March 2009: first documented case in the Midwestern United States. Am J Trop Med Hyg 83:1266–1268CrossRefPubMedPubMedCentral
34.
go back to reference Mulders MN, Reimerink JH, Koopmans MP, van Loon AM, van der Avoort HG (1997) Genetic analysis of wild-type poliovirus importation into The Netherlands (1979–1995). J Infect Dis 176:617–624CrossRefPubMed Mulders MN, Reimerink JH, Koopmans MP, van Loon AM, van der Avoort HG (1997) Genetic analysis of wild-type poliovirus importation into The Netherlands (1979–1995). J Infect Dis 176:617–624CrossRefPubMed
36.
go back to reference Inglesby TV, O’Toole T, Henderson DA, Bartlett JG, Ascher MS, Eitzen E et al (2002) Anthrax as a biological weapon, 2002: updated recommendations for management. JAMA 287:2236–2252CrossRefPubMed Inglesby TV, O’Toole T, Henderson DA, Bartlett JG, Ascher MS, Eitzen E et al (2002) Anthrax as a biological weapon, 2002: updated recommendations for management. JAMA 287:2236–2252CrossRefPubMed
38.
go back to reference Bhattacharjee Y (2011) Anthrax investigation. Army missed warning signs about alleged anthrax mailer. Science 332:27CrossRefPubMed Bhattacharjee Y (2011) Anthrax investigation. Army missed warning signs about alleged anthrax mailer. Science 332:27CrossRefPubMed
Metadata
Title
Survey of laboratory-acquired infections around the world in biosafety level 3 and 4 laboratories
Authors
N. Wurtz
A. Papa
M. Hukic
A. Di Caro
I. Leparc-Goffart
E. Leroy
M. P. Landini
Z. Sekeyova
J. S. Dumler
D. Bădescu
N. Busquets
A. Calistri
C. Parolin
G. Palù
I. Christova
M. Maurin
B. La Scola
D. Raoult
Publication date
01-08-2016
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 8/2016
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-016-2657-1

Other articles of this Issue 8/2016

European Journal of Clinical Microbiology & Infectious Diseases 8/2016 Go to the issue